Top compounds associated with response to MT-CYB


Feature Type Standardized
Nominal ANOVA
mRNA tamatinib CTRPv2 pan-cancer AAC 0.017 0.7
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA ML050 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA staurosporine CTRPv2 pan-cancer AAC 0.031 0.7
mRNA PF-543 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA L-685458 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Imatinib CTRPv2 pan-cancer AAC -0.016 0.7
mRNA AZ-3146 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.016 0.7
Download CSV